2m 2m 2m 2m 2m 2m 2m
Biolife Solution (BLFS)
NASDAQ
$27.25-$0.24 (-0.87%)
Price as of Jun 03, 2026 5:19 PM EDT- $1.2BMarket Cap
- 28.58%1-Year Change
- Medical Instruments & SuppliesIndustry
Biolife Solution (BLFS)
$27.25-$0.24 (-0.87%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 96.2M +16.97% | 82.3M -42.59% | 143.3M -11.43% | 161.8M +35.75% | |
Cost of Revenue | 34.1M +19.29% | 28.6M -70.39% | 96.5M -10.58% | 107.9M +31.46% | |
Gross Profit | 62.1M +15.74% | 53.7M +14.80% | 46.8M -13.14% | 53.8M +45.28% | |
Sales and Marketing Expense | 9.8M +2.50% | 9.6M -60.91% | 24.6M +13.97% | 21.6M +54.01% | |
Research and Development Expense | -7.6M -4.37% | -7.9M -57.91% | -18.8M +27.02% | -14.8M +25.18% | |
Depreciation and Amortization Expense | 2.3M -56.34% | 5.2M -0.41% | 5.2M -46.57% | 9.7M +18.23% | |
Total Operating Expenses | 78.7M -11.93% | 89.4M -58.25% | 214.1M -30.33% | 307.3M +100.72% | |
Operating Profit | -16.6M +132.88% | -7.1M -89.93% | -70.8M -51.34% | -145.5M +328.82% | |
Interest Income | 0 +100.00% | -4.1M N/A | 0 -100.00% | 697,000 N/A | |
Interest Expense | N/A N/A | -719,000 -60.32% | -1.8M +163.76% | -687,000 +59.03% | |
Interest Income and Expense and Net | 0 +100.00% | -4.8M +164.51% | -1.8M -18,220.00% | 10,000 +102.31% | |
Total Nonoperating Income and Expense | 4.5M +205.24% | -4.3M -194.07% | 4.6M +539.64% | 714,000 -88.46% | |
Income before Taxes | -12.1M +5.74% | -11.4M -82.76% | -66.3M -54.25% | -144.8M +421.84% | |
Income Taxes | 49,000 +228.95% | -38,000 -122.49% | 169,000 +103.37% | -5.0M -75.04% | |
Extraordinary Items | N/A N/A | N/A N/A | 15.5M -85.97% | 110.4M N/A | |
Net Income | -4.6M -77.23% | -20.2M -69.61% | -66.4M -52.49% | -139.8M +1,731.11% | |
Net Income from Continuing Operations Applicable to Common | -12.1M +6.52% | -11.4M -82.86% | -66.4M -52.49% | -139.8M +1,731.11% | |
Basic EPS and Net Income | -0.09 -79.55% | -0.44 -71.05% | -1.52 -53.80% | -3.29 +1,545.00% | |
Diluted EPS and Net Income | -0.10 -77.27% | -0.44 -71.05% | -1.52 -53.80% | -3.29 +1,545.00% | |
Basic Weighted Average Shares | 47.8M +3.66% | 46.1M +5.37% | 43.7M +2.91% | 42.5M +10.33% | |
Diluted Weighted Average Shares | 48.6M +5.60% | 46.1M +5.37% | 43.7M +2.91% | 42.5M +10.33% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 33.0M -65.36% | 95.4M +169.40% | 35.4M +82.12% | 19.4M -72.17% | |
Short-Term Investments | 55.9M +507.62% | 9.2M -43.53% | 16.3M -62.35% | 43.3M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 88.9M -14.97% | 104.6M +102.31% | 51.7M -17.55% | 62.7M -10.25% | |
Total Current Assets | 136.6M -8.20% | 148.8M +23.35% | 120.6M -12.89% | 138.5M +10.01% | |
Accumulated Depreciation | 4.9M +14.74% | 4.3M -54.75% | 9.5M +3.61% | 9.2M +36.05% | |
Property and Plant and Equipment and Net | 14.7M +141.83% | 6.1M -71.13% | 21.1M -10.83% | 23.6M +33.87% | |
Total Long-Term Assets | 3.0M -49.87% | 6.1M -71.13% | 21.1M -10.83% | 23.6M +33.87% | |
Total Assets | 405.9M +1.60% | 399.5M -3.20% | 412.7M -8.33% | 450.2M -18.74% | |
Income Taxes Payable | 2.5M -43.65% | 4.4M -22.20% | 5.6M +27.93% | 4.4M -19.79% | |
Total Short-Term Debt | 5.0M -54.34% | 10.9M +60.15% | 6.8M +276.68% | 1.8M +110.44% | |
Total Current Liabilities | 23.0M -29.80% | 32.7M -22.39% | 42.2M -5.39% | 44.6M +10.40% | |
Total Long-Term Debt | 0 -100.00% | 5.0M -72.71% | 18.3M -23.04% | 23.8M +274.52% | |
Total Long-Term Liabilities | 171,000 -99.05% | 18.0M N/A | 0 -100.00% | 10,000 -76.19% | |
Total Liabilities | 34.0M -32.79% | 50.6M -32.61% | 75.1M -12.77% | 86.0M +16.40% | |
Retained Earnings | -339.7M +1.37% | -335.1M +6.94% | -313.3M +26.90% | -246.9M +135.11% | |
Total Stockholders Equity | 371.9M +6.59% | 348.9M +3.33% | 337.7M -7.28% | 364.2M -24.15% | |
Total Shares Outstanding | 48.2M +2.75% | 46.9M +3.85% | 45.2M +5.45% | 42.8M +2.43% | |
Cash Flow | |||||
Cash from Operating Activities | 20.1M +138.58% | 8.4M +167.46% | -12.5M +47.24% | -8.5M +84.80% | |
Capital Expenditures | 9.5M +193.71% | 3.2M -49.43% | 6.4M -38.56% | 10.4M +23.85% | |
Cash from Investing Activities | -71.5M -222.71% | 58.3M +226.85% | 17.8M +130.69% | -58.1M +340.55% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -10.9M +61.05% | -6.8M -164.04% | 10.6M -35.09% | 16.3M +687.33% | |
Financials Ratio | |||||
Gross Margin | 64.56% -1.05% | 65.25% +99.96% | 32.63% -1.93% | 33.27% +7.01% | |
Operating Margin | -17.26% +99.09% | -8.67% -82.47% | -49.43% -45.06% | -89.97% +215.88% | |
Return on Assets | -1.14% -77.04% | -4.97% -67.72% | -15.40% -44.70% | -27.84% +1,338.40% | |
Return on Equity | -1.27% -78.31% | -5.88% -68.94% | -18.93% -42.84% | -33.12% +1,386.37% | |
Revenue Growth | 16.97% +139.85% | -42.59% +272.63% | -11.43% -131.97% | 35.75% -75.81% | |
Current Ratio | 5.94 +30.77% | 4.54 +58.93% | 2.86 -7.93% | 3.11 -0.36% | |
Cash Ratio | 1.44 -50.66% | 2.91 +247.11% | 0.84 +92.50% | 0.44 -74.79% | |
Debt-to-Equity Ratio | 0.01 -70.68% | 0.05 -38.66% | 0.07 +5.97% | 0.07 +368.67% | |
Debt-to-Assets Ratio | 0.01 -69.17% | 0.04 -34.48% | 0.06 +7.03% | 0.06 +337.69% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow